Dr. James Buxbaum, MD
Claim this profileLos Angeles County Hospital
Affiliated Hospitals
Los Angeles County Hospital
University Of Southern California
Clinical Trials James Buxbaum, MD is currently running
CyTOF Analysis
for Pancreatitis
The MoSAIC study is a prospective, observational study designed to develop an early prediction tool for severe acute pancreatitis (SAP) and define a distinct immunologic profile compared to moderate acute pancreatitis (MAP). The aims are to validate a new multi-cytokine panel for early prediction of SAP and to identify the specific immune cells that correspond with cytokine signatures in early acute pancreatitis to characterize the immune pathways driving the development of SAP. Participants will provide blood samples and complete patient surveys and interviews within 36 hours of hospital presentation, at 48 hours, and hospital day 7 (if admitted). Data on hospital stay, medical history, clinical course, and severity of disease will be collected.
Recruiting
1 award
N/A
5 criteria
Pancreatic Enzyme Replacement Therapy
for Pancreatic Insufficiency
This study aims to evaluate if a 6-month course of pancrelipase (CREON) treatment improves symptoms of exocrine pancreatic insufficiency (EPI) after an attack of acute pancreatitis. Diagnosis of EPI is measured by a fecal elastase value of \<200, and patients must have a qualifying symptom burden based on the EPI symptom tracker survey. Blood and stool will be analyzed as part of this study, and other surveys of health status will be used to track improvement of symptoms.
Recruiting
3 awards
Phase 4
2 criteria
More about James Buxbaum, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments James Buxbaum, MD has experience with
- AI Use In Endoscopy Room
- Non-AI Use Standard Of Care Endoscopy Room
- Initial Therapy With Papillary Balloon Dilation
- Initial Therapy With Intraductal Lithotripsy
- Ceftriaxone
- Levofloxacin
Breakdown of trials James Buxbaum, MD has run
Pancreatic Insufficiency
Pancreatitis
Colorectal Cancer
Choledocholithiasis, Cholangitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does James Buxbaum, MD specialize in?
James Buxbaum, MD focuses on Pancreatic Insufficiency and Pancreatitis. In particular, much of their work with Pancreatic Insufficiency has involved treating patients, or patients who are undergoing treatment.
Is James Buxbaum, MD currently recruiting for clinical trials?
Yes, James Buxbaum, MD is currently recruiting for 2 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that James Buxbaum, MD has studied deeply?
Yes, James Buxbaum, MD has studied treatments such as AI use in Endoscopy Room, Non-AI use Standard of Care endoscopy room, Initial therapy with papillary balloon dilation.
What is the best way to schedule an appointment with James Buxbaum, MD?
Apply for one of the trials that James Buxbaum, MD is conducting.
What is the office address of James Buxbaum, MD?
The office of James Buxbaum, MD is located at: Los Angeles County Hospital, Los Angeles, California 90033 United States. This is the address for their practice at the Los Angeles County Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.